Genera dd (VERNZ)

Zagreb
Currency in HRK
0.00
0.00(0.00%)
Closed·
Showing Genera dd historical data. For real-time data please try another search
Day's Range
0.000.00
52 wk Range
0.000.00
Key Statistics
Edit
Prev. Close
-
Open
150
Day's Range
-
52 wk Range
0-0
Volume
-
Average Volume (3m)
492
1-Year Change
193.09%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
No news in this category
Looks like there are no results in this news category

Genera dd Company Profile

Genera d.d. develops, produces, and sells pharmaceutical products in Croatia. The company’s animal health products include vaccines, antimicrobals, vitamins, diagnostics, antiparasitics, serums, and other products; antiseptics and disinfectants for veterinary use; and nutritional products for feeding swine, cattle, poultry, and other domestic animals. Its plant protection products comprise herbicides, insecticides, fungicides, mineral oils, growth regulators, foliar fertilizers, and disinsection and deratization products for use in agriculture to prevent the growth of weeds, outbreak of diseases, and unwanted insects that cause damages and minimize yields. In addition, the company’s pharmaceuticals consist of antiseptics and disinfectants, such as VITADERMAL products for washing and disinfection of hands and skin; VITAAREA products for cleaning and disinfection of various surfaces; and VITASEPTAL products, as well as generic medicines for clinical use in the treatment of cardiovascular, central-nervous, digestive, and respiratory systems. Further, it provides analytical services, including the analysis of raw materials and finished products; development, validation, and verification services; and transfer of analytical methods to pharmaceutical companies. The company was formerly known as Veterina d.d. and changed its name to Genera d.d. in June 2009. Genera d.d. was founded in 1901 and is headquartered in Rakov Potok, Croatia. Genera d.d. operates as a subsidiary of Dechra Pharmaceuticals plc.

Employees
236
Market
Croatia

Earnings

Latest Release
Nov 04, 2016
EPS / Forecast
-8.19 / --
Revenue / Forecast
104.07M / --
EPS Revisions
Last 90 days
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.